Nutrishield Beta-Carotene Attenuates LPS-Induced Systemic Inflammation and Oxidative Stress in Murine Model

This study demonstrates that Nutrishield's starch-based microencapsulation system significantly enhances the bioavailability and efficacy of beta-carotene, effectively attenuating LPS-induced systemic inflammation and oxidative stress in a murine model compared to non-encapsulated beta-carotene.

The Gist

The Big Idea: Saving a Superhero from Its Own Weakness

Imagine Beta-Carotene (a powerful antioxidant found in carrots and sweet potatoes) as a superhero whose job is to fight off "bad guys" in your body called free radicals and inflammation.

However, this superhero has a major flaw: it is very fragile. If you leave it out in the open air (oxygen) or try to send it through the rough and tumble of your digestive system, it falls apart before it can do its job. It's like sending a delicate glass statue through a rock tumbler; by the time it arrives, it's just dust.

The Problem: Scientists have known about this superhero for a long time, but because it breaks down so easily, it's hard to get it to work effectively inside the human body.

The Solution: The researchers created a special "body armor" for this superhero called Nutrishield®. This is a tiny, starch-based capsule (microencapsulation) that wraps the beta-carotene up tight, protecting it from air and helping it survive the journey through the stomach.

---

The Experiment: The "Fire Drill" in the Lab

To test if this new armor actually works, the researchers set up a dramatic experiment using mice.

1. The Villain (LPS): They injected the mice with a substance called LPS. Think of LPS as a "fire alarm" or a "fake bacterial attack." When the mice's bodies hear this alarm, they panic and start a massive fire (systemic inflammation). Their immune systems go into overdrive, releasing toxic smoke (cytokines) that damages their organs (liver and kidneys).
2. The Teams: They split 32 mice into four groups to see who could put out the fire best:
   • The Control Group: Got nothing (just water).
   • The Fire Group: Got the "fire alarm" (LPS) but no help.
   • The Old Hero Group: Got the fire alarm + the unprotected Beta-Carotene (the superhero without armor).
   • The Armored Hero Group: Got the fire alarm + the Nutrishield® Beta-Carotene (the superhero in body armor).

The Results: Who Won the Battle?

After 28 days, the researchers checked the mice's blood and organs. Here is what they found:

• The Fire Group (LPS only): As expected, these mice were in bad shape. Their "fire alarm" levels (inflammatory markers like TNF-α and IL-6) were sky-high. Their organs were damaged, showing signs of "burns" (cellular damage and swelling).
• The Old Hero Group (Unprotected Beta-Carotene): This superhero tried to help, but because it was unprotected, it mostly fell apart on the way. It managed to put out a little bit of the fire, but the mice were still quite sick.
• The Armored Hero Group (Nutrishield®): This was the clear winner. Because the beta-carotene was protected by the Nutrishield® armor:
  • It survived the journey: More of the active ingredient actually reached the bloodstream.
  • It put out the fire: The levels of inflammatory "smoke" dropped dramatically, almost back to normal levels.
  • It saved the organs: The liver and kidneys looked healthy, with very little damage compared to the other groups.
  • It boosted the good guys: It increased the levels of "peacekeeper" chemicals (anti-inflammatory cytokines) that calm the body down.

The "Why" Behind the Magic

Why did the armored version work so much better?

1. The Starch Suit: The Nutrishield® uses a starch matrix (like a tiny, edible bubble wrap) that stops oxygen from destroying the beta-carotene before it's needed.
2. The Vitamin E Shield: They added Vitamin E to the mix, which acts like a secondary shield, further protecting the beta-carotene from rusting (oxidizing).
3. The Delivery System: The starch helps the body recognize the beta-carotene as a nutrient it can easily absorb, rather than something it needs to reject.

The Bottom Line

Think of Nutrishield® not just as a vitamin, but as a delivery truck with a secure vault.

If you just throw a package of vitamins into a chaotic city (your body), they might get lost or destroyed. But if you put them in a secure, armored truck (Nutrishield®), they arrive safely at the destination (your cells) ready to do their job.

In simple terms: This study proves that wrapping Beta-Carotene in this special starch armor makes it much stronger, more stable, and much better at fighting inflammation than the regular, unprotected version. It turns a fragile superhero into an unstoppable force for health.

Technical Summary

1. Problem Statement

The Challenge of β-Carotene Bioavailability:
While β-carotene is a potent antioxidant and immunomodulator, its therapeutic application is limited by poor physicochemical stability. It is highly susceptible to oxidation in oxygen-rich environments and degrades during digestion and storage, leading to low bioavailability and inconsistent biological efficacy.
The Research Gap:
There is a lack of comparative data evaluating novel microencapsulation delivery systems against pure, unencapsulated β-carotene in the context of systemic inflammation. Existing studies often fail to demonstrate whether formulation improvements translate to significant in vivo organ protection and cytokine modulation compared to standard β-carotene.

2. Methodology

Study Design:

• Model: A murine model of systemic inflammation induced by Lipopolysaccharide (LPS) in male BALB/c mice ($n=32$, 4 groups, $n=8$ per group).
• Groups:
  1. Control: Saline (i.p.) + Corn oil (oral).
  2. LPS: LPS (1 mg/kg, i.p., twice weekly) + Corn oil.
  3. LPS + β-Carotene: LPS + Unencapsulated β-carotene (10 mg/kg/day, oral).
  4. LPS + Nutrishield®: LPS + Nutrishield® β-Carotene (equivalent 10 mg/kg/day, oral).
• Duration: 28 days.
• Induction: LPS (E. coli 055:B5) injected intraperitoneally on days 1, 4, 8, 12, 16, 20, 24, and 28.

The Intervention (Nutrishield®):

• Formulation: A starch-based microencapsulation system (20% TAB-S) containing modified food starch, corn starch, and all-rac-α-tocopherol (Vitamin E) as a stabilizer.
• Mechanism: Designed to protect β-carotene from oxidation, mimic natural lipid absorption, and enable controlled release in the gastrointestinal tract.

Assessments:

• Serum Cytokines: ELISA for TNF-α, IL-6, and IL-10.
• Oxidative Stress: 8-OHdG (oxidative DNA damage marker) and Total Antioxidant Capacity (TAC) via FRAP assay.
• Organ Function: Serum ALT, AST (liver), Urea, and Creatinine (kidney).
• Histopathology: H&E staining of liver and kidney tissues to assess vacuolation, necrosis, and inflammation.
• Statistical Analysis: One-way ANOVA with Tukey's post hoc test ($p < 0.05$).

3. Key Contributions

• Comparative Efficacy: The study provides direct evidence that microencapsulated β-carotene (Nutrishield®) outperforms unencapsulated β-carotene in mitigating LPS-induced damage.
• Mechanistic Insight: It links the improved physicochemical stability of the starch-tocopherol matrix to enhanced in vivo bioavailability and sustained antioxidant activity.
• Organ Protection: It demonstrates that the formulation not only reduces systemic markers but also provides tangible histological protection to the liver and kidneys, organs highly susceptible to LPS toxicity.
• Platform Validation: The research validates Nutrishield® as a versatile delivery platform for lipophilic bioactives, suggesting potential applications for other vitamins (e.g., Vitamin B5).

4. Key Results

A. Cytokine Modulation (Anti-inflammatory Effect)

• LPS Challenge: Significantly elevated pro-inflammatory cytokines (TNF-α: $142 \pm 8$ pg/mL; IL-6: $118 \pm 7$ pg/mL) compared to controls.
• Nutrishield® Efficacy:
  • Reduced TNF-α to $69 \pm 4$ pg/mL (near baseline) and IL-6 to $56 \pm 3$ pg/mL.
  • Comparison: Nutrishield® reduced TNF-α by 51% compared to the LPS group and 26% compared to the unencapsulated β-carotene group.
  • Anti-inflammatory Shift: IL-10 (anti-inflammatory) levels increased significantly ($76 \pm 3$ pg/mL) in the Nutrishield® group, a 100% increase over the LPS group.

B. Oxidative Stress Reduction

• DNA Damage: LPS increased serum 8-OHdG (marker of oxidative DNA damage) to $5.4 \pm 0.3$ ng/mL. Nutrishield® reduced this to $2.3 \pm 0.2$ ng/mL (a 57% reduction vs. LPS).
• Antioxidant Capacity: Nutrishield® restored Total Antioxidant Capacity (TAC) to $2.5 \pm 0.1$ mM Trolox equivalents, which was 64% higher than the unencapsulated β-carotene group ($1.52$ mM).

C. Organ Function and Histopathology

• Liver/Kidney Biochemistry: Nutrishield® normalized ALT, AST, Urea, and Creatinine levels, reducing hepatic enzyme elevation by ~55% and renal markers by ~40% compared to the LPS-only group.
• Histology:
  • LPS Group: Showed severe hepatocellular vacuolation, inflammatory infiltration, glomerular congestion, and tubular necrosis.
  • Nutrishield® Group: Exhibited nearly normal tissue morphology with minimal inflammation, significantly outperforming the unencapsulated β-carotene group which showed only partial restoration.

5. Significance and Conclusion

This study establishes that Nutrishield® microencapsulation significantly enhances the therapeutic index of β-carotene. By protecting the molecule from degradation and improving its dispersion and absorption, the formulation transforms β-carotene from a labile compound into a robust therapeutic agent.

• Clinical Implication: The findings suggest that Nutrishield® β-Carotene could be a superior nutraceutical intervention for conditions driven by chronic inflammation and oxidative stress, such as metabolic syndrome, NAFLD, cardiovascular disease, and inflammatory bowel disease.
• Future Outlook: The authors propose that the starch-based platform is scalable for other bioactives (e.g., Vitamin B5) and warrants further investigation through regulated human clinical trials to confirm translational potential.

Note: The manuscript is currently a preprint (bioRxiv) and has not yet undergone peer review. The authors declare competing financial interests as employees of the companies developing and distributing the product.